Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / DAFNA Capital Management LLC
Form 13F · Q2 2026

DAFNA Capital Management LLC

CIK 1389933申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$5.2亿
申報組合市值
88
持倉數量
12
Quarters on record
Top 50
持倉數量

DAFNA Capital Management LLC——持倉

共 88 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1RVMD Revolution Medicines Inc562,630−3.1%$1.1亿20.1%
2SPDR SERIES TRUST Spdr Series Trust196,505−38.3%$3110万5.9%
3CMPS Compass Pathways Plc2.0M−16.8%$2847万5.4%
4STXS Stereotaxis Inc13.7M+0.0%$2353万4.5%
5NKTR Nektar Therapeutics318,380+92.7%$2223万4.2%
6DNLI Denali Therapeutics Inc739,014+132.0%$1901万3.6%
7IDYA Ideaya Biosciences Inc497,240+4.3%$1853万3.5%
8ATRC Atricure Inc597,431+0.0%$1672万3.2%
9XENE Xenon Pharmaceuticals Inc250,772+0.0%$1514万2.9%
10CYTK Cytokinetics Inc171,998−20.9%$1465万2.8%
11RCUS Arcus Biosciences Inc441,829−0.5%$1362万2.6%
12ASND Ascendis Pharma A/S48,469—$1293万2.5%
13NBIX Neurocrine Biosciences Inc57,769−18.2%$974万1.9%
14AXGN Axogen Inc208,960−16.4%$965万1.8%
15PODD Insulet Corp61,870+469.2%$942万1.8%
16EWTX Edgewise Therapeutics Inc226,819+102.1%$922万1.8%
17BCAX Bicara Therapeutics Inc284,955−32.4%$846万1.6%
18ISHARES TR Ishares Tr42,595−31.4%$810万1.5%
19SNDX Syndax Pharmaceuticals Inc335,255+54.2%$733万1.4%
20MPLT Maplight Therapeutics Inc171,006+0.0%$613万1.2%
21LRMR Larimar Therapeutics Inc2.0M−1.0%$612万1.2%
22IPSC Century Therapeutics Inc2.4M−1.4%$588万1.1%
23DXCM Dexcom Inc86,279+0.0%$581万1.1%
24IMVT Immunovant Inc149,524−0.7%$576万1.1%
25INGN Inogen Inc845,179+0.0%$545万1.0%
26TNDM Tandem Diabetes Care Inc355,208+0.0%$536万1.0%
27ALKS Alkermes Plc101,266−27.4%$531万1.0%
28STOK Stoke Therapeutics Inc130,875+0.0%$428万0.8%
29ALLO Allogene Therapeutics Inc2.0M+46.0%$416万0.8%
30BCRX Biocryst Pharmaceuticals Inc400,248−7.0%$400万0.8%
31LKFT Lakefront Biotherapeutics130,175+0.0%$390万0.7%
32KIDS Orthopediatrics Corp189,130+97.7%$362万0.7%
33HELP Cybin Inc514,061+3.2%$340万0.6%
34RAPP Rapport Therapeutics Inc75,000+0.0%$313万0.6%
35KYMR Kymera Therapeutics Inc27,000—$310万0.6%
36PRQR Proqr Thrapeutics N V1.5M−2.4%$285万0.5%
37NGNE Neurogene Inc89,032+57.2%$280万0.5%
38ANL Adlai Nortye Ltd239,553—$275万0.5%
39PRCT Procept Biorobotics Corp120,000+0.0%$271万0.5%
40AQST Aquestive Therapeutics Inc645,915+75.3%$269万0.5%
41CLDX Celldex Therapeutics Inc New68,518+0.0%$255万0.5%
42GPCR Structure Therapeutics Inc46,500+0.0%$250万0.5%
43ALGN Align Technology Inc14,000−6.7%$236万0.5%
44VKTX Viking Therapeutics Inc59,516+0.0%$232万0.4%
45NGEN Nervgen Pharma Corp1.1M—$216万0.4%
46BHVN Biohaven Ltd137,593−83.7%$205万0.4%
47MAZE Maze Therapeutics Inc65,000+85.7%$194万0.4%
48ALEC Alector Inc908,351+0.0%$183万0.3%
49LXEO Lexeo Therapeutics Inc377,059+0.0%$176万0.3%
50PROF Profound Med Corp260,360−1.0%$173万0.3%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。